Benzinga | Nov 12, 2021 10:58AM EST

A Preview Of Kala Pharmaceuticals's Earnings

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement.

Analysts estimate that Kala Pharmaceuticals will likely report an Earnings Per Share (EPS) of $-0.43

Kala Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat on EPS by 26.67%, which was followed by a 1.26% drop in the share price the next day.

Here's a look at Kala Pharmaceuticals's past performance and the resulting price change:

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020EPS Estimate -0.45 -0.68 -0.46 -0.44EPS Actual -0.57 -0.49 -0.55 -0.50Price Change % -1.26% -11.43% -4.2% -1.93%

Stock Performance

Shares of Kala Pharmaceuticals were trading at $2.09 as of November 11. Over the last 52-week period, shares are down 71.32%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

If you want to track all upcoming earnings announcements, check out our Earnings Calendar here